Event Overview
The Future of Sterile Injectable Supply
Global Scalability, Local Precision: Bridging Aseptic Fill-Finish from Albuquerque to Glasgow
This invitation-only dinner takes place during the opening night of CPHI Milan and is designed for senior leaders navigating the transition from clinical supply to commercial manufacturing.
Contributing company
CuriaEvent Details
Date
6th October 2026
Venue
Langosteria Via Savona, 10, 20144 Milano MI, Italy
Format
Exclusive Roundtable Dinner
Biotech Targeting handles transport from Fiera Milano to Langosteria for all confirmed delegates.
Attendance is strictly limited to 10-15 senior industry leaders.
Main Event Description
Join global pharmaceutical pioneers and industry executives for an exclusive roundtable dinner during the opening night of CPHI Milan 2026. As the drug development pipeline shifts rapidly toward low-volume specialized therapies, advanced biologics, and highly potent drug products, finding agile and scalable CDMO infrastructure remains a vital strategic imperative. This private, peer-to-peer dinner will outline how Curia is meeting these market adjustments through multi-million dollar investments across its core transatlantic facilities. Through expert panel dialogue, Curia leadership will showcase how expansion projects in Albuquerque, USA, and Glasgow, UK work in unison to eliminate supply chain risks. Attendees will gain an inside look into high-speed automated vial inspection networks, small-scale biologics flex lines, and expanded clinical-to-commercial lyophilization capabilities. Secure your place at the table to build a more resilient clinical pathway and ensure your therapy navigates seamlessly from idea to lasting global impact.
Key Benefits of Attending
Make the right connections at the opening night of CPHI Milan
A focused evening combining expert dialogue, strategic discussion, fine dining, and qualified networking.
Explore Transatlantic Fill-Finish Synergies
Understand how Curia connects its Albuquerque and Glasgow capabilities to support agile, scalable sterile injectable programs.
Build a More Resilient Supply Chain
Discuss practical ways to reduce global supply risk as low-volume specialized therapies and advanced biologics move toward commercialization.
See the Capabilities Behind Global Scale
Gain insight into automated vial inspection, small-scale biologics flex lines, and expanded clinical-to-commercial lyophilization capacity.
Connect with Senior Industry Leaders
Join a private peer-to-peer conversation with senior CMC, Technical Operations, Supply Chain, and manufacturing decision-makers.
Who Should Attend
Senior Biopharma Decision-Makers
Specifically designed for senior leaders navigating the transition from clinical supply to commercial manufacturing.
Chief Technical Officer (CTO) / Chief Operating Officer (COO)
VP / SVP of Tech Ops, CMC, or Quality Operations
Head of Commercial Manufacturing or Sterile Operations
Director of Process Validation, Engineering, or Global Supply Chain
Senior Director of Quality Assurance, Compliance, and Regulatory Affairs
Agenda
Evening Schedule
A focused dinner format designed for senior peer exchange, practical insight, and qualified networking.
Registration & Welcome Aperitif
Roundtable Discussion: Transatlantic Fill-Finish Synergies
Curated Fine Dining & Strategic Discussion
Concluding Remarks, Dessert, & Executive Networking
Speakers
Hear from the Curia leadership and industry experts shaping the future of sterile injectable supply.
About Curia
Curia supports programs from early-stage development through commercial manufacturing, with services across drug product development, clinical manufacturing, and commercial manufacturing. Its network provides sterile fill-finish capabilities, formulation and process development support, lyophilization expertise, and capacity in vials, pre-filled syringes, and cartridges. Curia works with complex APIs and sterile injectable formats, including solutions, suspensions, emulsions, lipid nanoparticles, and lyophilized dosage forms. Its sterile drug product sites include clinical development and manufacturing locations in Camarillo, California, and Glasgow, UK, as well as a commercial sterile drug product location in Albuquerque, New Mexico, supporting late-phase clinical and commercial work.
An Exclusive, Executive-Level Gathering
Register Now
To keep the conversation flowing and meaningful, attendance is strictly limited to 10-15 CMC, Supply Chain, and Technical Operations executives. This private, invitation-only dinner is designed to offer a relaxed setting to discuss how Curia's expansions in Glasgow, UK and Albuquerque, USA work in unison to eliminate global supply chain risks.
Registration is entirely complimentary, including private dining and drinks during CPHI Milan opening night. Due to strict venue capacity constraints, seats will be allocated on a first-come, first-served basis to qualified industry leaders.
Secure your place at the table today to unwind with your peers, talk a little science, and discover how to build a more resilient clinical pathway from idea to global impact.
Register Now
Attendance is limited to 10-15 senior leaders.
Registration is fully complimentary, including private dining and drinks during CPHI Milan opening night.